secwatch / observer
8-K filed October 31, 2025, 7:59 PM ET CIK 0001758057
other material confidence high sentiment negative materiality 1.00

Luminar faces going concern doubt; CFO exits, 25% layoffs, Volvo removes Iris as standard option

Luminar Technologies, Inc./DE

item 1.01item 2.02item 2.05item 5.02item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001758057-25-000006
form_type
8-K
ticker
null
cik
0001758057
company_name
Luminar Technologies, Inc./DE
filed_at
2025-10-31T23:59:59+00:00
discovered_at
2026-05-14T18:02:40.351528+00:00
generated_at
2026-05-17T01:08:10.622028+00:00
sec_items
["1.01", "2.02", "2.05", "5.02", "8.01", "9.01"]
event_type
other_material
sentiment
negative
materiality_score
1.0
calibrated_materiality_score
1.0
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001758057-25-000006
json_url
https://secwatch.observer/filing/0001758057-25-000006.json
markdown_url
https://secwatch.observer/filing/0001758057-25-000006.md
text_url
https://secwatch.observer/filing/0001758057-25-000006.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1758057/000175805725000006/0001758057-25-000006-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1758057/000175805725000006/lazr-20251030.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

ad3f1bb31000f03bc0eb99966866ef36540893cf

Luminar Technologies, Inc./DE announced a restructuring with charges of approximately $2.0 million to $3.0 million in cash charges (approximately 25%).

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

SEC 8-K Item 2.05/2.06 confidence 0.9 SEC evidence

Comparable filings

ORGN

Origin Materials board approves dissolution, liquidation; CEO steps down; workforce cut 59%

Origin Materials, Inc. May 1, 2026, 7:59 PM ET other_material Items 2.05, 5.02, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 5.02, 9.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

its workforce by approximately 59%, resulting in an approximately $14.0 million decrease in annual operating expenses. Origin anticipates that it will incur approximately $2.1 million in restructuring charges in connection with the workforce reduction, primarily consisting of cash expenditures of approximately $2.1 million for severance and benefits costs.

Filing page SEC filing

GO

Grocery Outlet Q4 net loss $218M; to close 36 stores in 2026

Grocery Outlet Holding Corp. March 4, 2026, 6:59 PM ET other_material Items 2.02, 2.05, 9.01

same fact type: restructuring_charge same SEC item: 2.02, 2.05, 9.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

The Company estimates that it will incur between $14 million and $25 million in net total restructuring charges in fiscal 2026 related to the Optimization Plan approved in the first quarter of fiscal 2026.

Filing page SEC filing

XYZ

Block reports Q4 gross profit $2.87B (+24% YoY); cuts workforce >40%

Block, Inc. February 26, 2026, 6:59 PM ET other_material Items 2.02, 2.05, 9.01

same fact type: restructuring_charge same SEC item: 2.02, 2.05, 9.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

On February 26, 2026, the Company announced a workforce reduction restructuring plan (the “Workforce Plan”) designed to better align our organizational structure with our operating model and strategic priorities. As part of the Workforce Plan, we expect to reduce our current workforce by more than 40%. The Company currently estimates that we will incur charges of approximately $450 million to $500 million in connection with the Workforce Plan

Filing page SEC filing

LYRA

Lyra suspends LYR-210 development, lays off nearly all staff; CEO/CFO become consultants

Lyra Therapeutics, Inc. January 12, 2026, 6:59 PM ET other_material Items 2.05, 5.02, 8.01

same fact type: restructuring_charge same SEC item: 2.05, 5.02, 8.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

On January 9, 2026, the Board of Directors of Lyra Therapeutics, Inc. (the “Company”) approved a plan to suspend further development of LYR-210, the Company’s lead product candidate for the treatment of chronic rhinosinusitis, and to implement a cost reduction plan that includes a workforce reduction impacting substantially all of the Company’s remaining employees, effective January 12, 2026, and other cost-saving actions to preserve capital (the “Plan”).

Filing page SEC filing

CRMT

America's Car-Mart to close 42 stores (31% of total); non-cash impairment ~$14M due to capital constraints

AMERICAS CARMART INC April 7, 2026, 7:59 PM ET other_material Items 2.05, 2.06, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 9.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.

Filing page SEC filing

WLK

Westlake approves closure of three chlorovinyl plants and styrene unit, expects $415M in pre-tax costs

WESTLAKE CORP December 15, 2025, 6:59 PM ET other_material Items 2.05, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 9.01 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Filing page SEC filing

PASG

Passage Bio cuts ~75% of workforce, expects $3.3M in severance costs

Passage BIO, Inc. April 28, 2026, 7:59 PM ET other_material Items 2.05

same fact type: restructuring_charge same SEC item: 2.05 same event type: other_material similar materiality

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

The Company expects that the aggregate severance and exit costs for the Restructuring Plan will be approximately $3.3 million, which will be recorded primarily in the second quarter of 2026.

Filing page SEC filing

BCAB

BioAtla initiates strategic review, cuts 70% workforce; CFO replaced; cash ~$7.1M

BioAtla, Inc. March 2, 2026, 6:59 PM ET other_material Items 2.02, 7.01, 2.05, 5.02, 8.01, 9.01

same fact type: restructuring_charge same SEC item: 2.02, 2.05, 5.02, 8.01, 9.01 same event type: other_material

This filing

On October 29, 2025, the Company committed to a plan to reduce its workforce by approximately 25% in order to reduce operating costs. The reduction will commence immediately and is expected to be substantially completed by 2025 year-end. The Company estimates that it will incur approximately $2.0 million to $3.0 million in cash charges associated with employee severance and related employee costs, to be incurred primarily in the fourth quarter of 2025.

Comparable filing

formal process to explore and evaluate strategic options to maximize shareholder value. The total cash payments related to this workforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company expects to pay for the majority of these costs in the first quarter of 2026. The estimates of the

Filing page SEC filing

Source: SEC EDGAR
accession 0001758057-25-000006
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.